BioElectronics Corp. and Locin Industries Ltd. Bring ActiPatch(TM) to Canadian Retail Market

Wednesday, May 14, 2008 General News
Email Print This Page Comment bookmark
Font : A-A+

FREDERICK, Md., May 13 BioElectronics Corp.(Pink Sheets: BIEL), the maker of ActiPatch(TM), a drug free anti-inflammatorypatch, with an embedded battery operated microchip, which delivers weeks ofcontinuous pulse therapy for a few cents an hour, and Locin IndustriesLimited, one of Canada's leading distributors to the Canadian retail sectortoday announced the upcoming launch of the ActiPatch brand into the Canadianretail sector. Through this partnership, national and regional retailers andwholesalers in the grocery, drug mass merchandise and club channels acrossCanada will begin stocking ActiPatch products beginning this summer. Inadvance of the retail launch, Canadian consumers can purchase the ActiPatchdirectly at ActiPatchPainTherapy.ca.

"We are very pleased to partner with Locin to bring this revolutionaryproduct to the Canadian retail marketplace. Since receiving our Health Canadaapproval, interest in our drug-free, anti-inflammatory patch products isincreasing and we are very excited that Canadian consumers will be able toeasily purchase our product by simply visiting a local retailer," commentedAndrew Whelan, president and CEO of BioElectronics Corporation. "Our companyis all about speeding recovery of injury and reducing pain and we are veryhappy that Canadian consumers will soon be able to enjoy the significantbenefits of our products," explains Whelan.

Brad Collins, Vice President of Locin Industries Ltd. adds, "Our keystrengths are our customer and vendor relationships that we have fostered forover 30 years. We believe we will be able to leverage these strengths inorder to effectively launch this significant new product into the Canadianmarket. We are very pleased to be working with BioElectronics Corporation onthis endeavor and look forward to providing our national and regionalretailers and wholesalers with what we believe will be a very popular productwith Canadian consumers."

About BioElectronics Corporation

BioElectronics Corporation is the maker of the ActiPatch(TM). ActiPatchis a drug-free anti-inflammatory patch with an embedded battery operatedmicrochip that delivers weeks of continuous pulsed therapy for about a dollara day. The unique ActiPatch delivery system, using patented technology,provides a cost-effective patient friendly method to reduce soft tissue painand swelling. ActiPatch is approved by Health Canada for the relief of painin musculoskeletal complaints. The US government's food and drugadministration (FDA) has cleared the use of the product for reducing edema(swelling) following blepharoplasty and the European Union has approved theproduct as a class two pulsed electromagnetic medical device as have numerousother international record for agencies. Information on ActiPatch andBioElectronics Corporation is available at the following websites:

Safe Harbor Statement

This news release contains forward-looking statements related to futuregrowth and earnings opportunities. Such statements are based upon certainassumptions and assessments made by management of both companies In light ofcurrent conditions, expected future developments and other factors it believesto be appropriate. Actual results may differ as a result of factors overwhich the company has no control.

About Locin Industries Ltd.

Locin Industries Ltd., headquartered in North Vancouver, British Columbia,is a full service distributor serving all national and regional retailers andwholesalers in the grocery, drug, mass merchandise and club channels inCanada. The family-owned and operated company relies heavily on its customerand vendor relationships that have been fostered over a period spanning morethan 30 years to provide effective brand and category management includingretail head office liaison, trade and consumer advertising, promotionaldevelopment and planning, data analysis and forecasting, and


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store